Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
about
Fluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityFluid and diuretic therapy for preventing cisplatin-induced nephrotoxicityMechanisms of Cisplatin nephrotoxicityAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityRenal salt wasting in patients treated with high-dose cisplatin, etoposide, and mitomycin in patients with advanced non-small cell lung cancerHypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycinNutritional aspects of magnesium metabolism.Toxicities of the platinum antineoplastic agents.Cisplatin therapy-associated recurrent toxic shock syndrome.Risk of ischemic stroke in patients with ovarian cancer: a nationwide population-based study.Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in ratsTesticular cancer survivorship: research strategies and recommendations.A clinical approach to common electrolyte problems: 4. Hypomagnesemia.Lack of effect of oral magnesium on high blood pressure: a double blind studyPrevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.Magnesium deficiency in critical illness.Effects of magnesium supplementation in testicular cancer patients receiving cis-platin: a randomised trial.Effect of Oral Magnesium Oxide Supplementation on Cisplatin-Induced Hypomagnesemia in Cancer Patients: A Randomized Controlled Trial.Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.Cisplatin overdose: toxicities and management.Assessment of chemotherapy-associated nephrotoxicity in children with cancer.Risk of anti-EGFR monoclonal antibody-related hypomagnesemia: systematic review and pooled analysis of randomized studies.Magnesium homeostasis and hypomagnesemia in children with malignancy.Cisplatin induced paroxysmal supraventricular tachycardia.Cisplatin-induced renal toxicity magn…ified: role of magnesium deficiency in AKI onset.The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance.Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.Cisplatin nephrotoxicity. A review.Quantitative analysis of Gd@C82(OH)22 and cisplatin uptake in single cells by inductively coupled plasma mass spectrometry.Cisplatin nephrotoxicity: a review of the literature.Magnesium and cardiac arrhythmias: nutrient or drug?Cisplatin: a review of clinical applications and renal toxicity.Clinical pharmacology of bleomycin and cisplatin.Newer insights into cisplatin nephrotoxicity.Severe vascular toxicity associated with cisplatin-based chemotherapy.Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial studyThe influence of age on nephrotoxicity following chemotherapy in children[Side-effects of polychemotherapy in metastatic testicular neoplasms (author's transl)].A randomised study comparing intermittent to continuous administration of magnesium aspartate hydrochloride in cisplatin-induced hypomagnesaemia.
P2860
Q24236119-E9A04A4D-C4F5-40B6-AC03-AE7DB541B5FFQ24242032-082EFDBB-0753-47AC-B261-8BF93B82A01CQ26996320-5A2BDD24-479E-4387-87FE-427F3F6F3978Q28080615-A37843AA-B7C6-4917-9DBB-B394916187CCQ28327236-AAB924A7-1114-4CC7-9557-ED4B7362F060Q28336414-BA51396B-AFD4-4A06-9C5D-D83464BDAB13Q28769130-1B27FFBB-F8CF-4701-8080-F79699880823Q33357351-DAD24171-54FC-4692-8A3D-CB4053F324CCQ33559667-142F2497-745B-4637-AE40-05D2515567B8Q33616584-D3004321-53C5-4AC9-B5A4-1F3988D0D6B5Q33805488-85B78E1C-127D-4385-A29F-AF24EBE2D662Q34039684-0686B135-7B1E-4343-AA39-6A555B9FFE1FQ34298911-D19C6075-8FF4-417B-A500-61E4D003306AQ34487369-EB8AF350-9E3B-45DB-BF2A-2355929031A9Q34589066-8EB1FC64-822E-4B81-80F1-7DECD5131DADQ36017593-CCE1B6C9-45B8-4934-BE8F-64085037D8AFQ36027863-988571FE-044D-47E2-BFB8-671744012011Q36769780-82C6FD74-E193-4A94-98D0-130AEDCA2B92Q36948510-EF70A5A0-F0C7-48CF-93A2-571CEDE681BFQ37633516-8E02AAE4-BF6A-4B43-938C-6D9B9EF76F7DQ37769903-22BA4705-8D16-4546-8B27-604E0860A41EQ37917796-70EAD68E-C9E9-4731-9128-AE0D5D2D8D95Q38072879-E76D5931-6E5F-49EF-8EFC-7CF2B133FDC5Q38194125-65A83471-355D-4420-BE66-86AE234C1D26Q38618836-EA658C1F-37B7-477B-B782-AA300DC1D88EQ38620778-0FF8D064-36E7-4DB0-A30B-6769588B7F65Q38637751-0D4E7D97-4826-42B9-AECF-DE09F3E3D43EQ38668802-2303C03A-EC8C-44F4-A2FB-531742160DA9Q38730217-27D3D6C0-F0F3-4600-B649-337C05DE3C24Q38907617-2793ED45-86D5-4CBF-BA47-4C6975091F6FQ39223600-06B5FCF2-8524-4990-8847-9FD4D3530E56Q39749171-5DF50871-9CDC-4880-AB4D-9628FB68FC48Q39837837-CE9A1EC5-D0C5-48C1-BE66-AB7924A503E8Q40101938-BFDE2133-AD92-4305-BBAE-0226629DB837Q40813475-9C18FA7D-BDFF-4322-BD1C-9667789A97DDQ40819760-B81BEDB8-8FC2-4A9E-A507-C0DFBD21B50EQ40831749-B15AC47B-9F41-4177-B9B2-AF97EB7F03D8Q41111173-BAEDF5E7-7DBC-47E8-B8D0-5D520DC5DF6EQ42243197-BDA624ED-2A25-476B-AD9A-8DE170706265Q42383916-6D6179B4-E628-4F90-BFC9-77858E6AEFE3
P2860
Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
@en
type
label
Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
@en
prefLabel
Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
@en
P1476
Hypomagnesemia and renal magnesium wasting in patients receiving cisplatin.
@en
P2093
Anderson T
Schilsky RL
P304
P356
10.7326/0003-4819-90-6-929
P407
P577
1979-06-01T00:00:00Z